ImplementationGuide for Malaysia Core (MY Core)
0.0.1 - CI Build
ImplementationGuide for Malaysia Core (MY Core), published by Malaysia Healthcare Nexus (MHN). This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/nhphong245/my-core-ig-r4/ and changes regularly. See the Directory of published versions
Official URL: http://fhir.hie.moh.gov.my/ValueSet/loinc-my-core | Version: 0.0.1 | |||
Active as of 2024-02-12 | Responsible: Malaysia Healthcare Nexus (MHN) | Realm: | Computable Name: ValueSetLoincMyCore |
LOINC value set
References
Generated Narrative: ValueSet
Expansion based on Loinc v2.78
This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
Code | System | Display |
100000-9 | http://loinc.org | Health informatics pioneer and the father of LOINC |
100001-7 | http://loinc.org | Health informatics pioneer and cofounder of LOINC |
100002-5 | http://loinc.org | Specimen care is maintained |
100003-3 | http://loinc.org | Team communication is maintained throughout care |
100004-1 | http://loinc.org | Demonstrates knowledge of the expected psychosocial responses to the procedure |
100005-8 | http://loinc.org | Demonstrates knowledge of nutritional management related to the procedure |
100006-6 | http://loinc.org | Demonstrates knowledge of medication management |
100007-4 | http://loinc.org | Demonstrates knowledge of pain management |
10000-8 | http://loinc.org | R wave duration in lead AVR |
100008-2 | http://loinc.org | Demonstrates knowledge of wound management |
100009-0 | http://loinc.org | Demonstrates knowledge of the procedure and expected results |
100010-8 | http://loinc.org | No injury related to procedure equipment, medical supplies, or instrumentation |
100011-6 | http://loinc.org | No injury related to an electrical source |
100012-4 | http://loinc.org | Participates in decisions affecting the patient's plan of care |
100013-2 | http://loinc.org | Participates in the discharge process |
100014-0 | http://loinc.org | Psychosocial health is maintained at or improved from baseline |
100015-7 | http://loinc.org | No injury related to positioning due to care or procedure |
10001-6 | http://loinc.org | R wave duration in lead I |
100016-5 | http://loinc.org | No injury related to a laser source |
100017-3 | http://loinc.org | Perioperative nursing data set outcomes panel [PNDS] |
100018-1 | http://loinc.org | Hospice care Note |
100019-9 | http://loinc.org | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100020-7 | http://loinc.org | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100021-5 | http://loinc.org | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100022-3 | http://loinc.org | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100023-1 | http://loinc.org | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
10002-4 | http://loinc.org | R wave duration in lead II |
100024-9 | http://loinc.org | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100025-6 | http://loinc.org | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100026-4 | http://loinc.org | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100027-2 | http://loinc.org | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100028-0 | http://loinc.org | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100029-8 | http://loinc.org | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method |
100030-6 | http://loinc.org | Axis I: Temporal aspects score [Mainz Pain Staging System] |
100031-4 | http://loinc.org | Axis II: Spatial aspects score [Mainz Pain Staging System] |
10003-2 | http://loinc.org | R wave duration in lead III |
100032-2 | http://loinc.org | Axis III: Drug taking behavior score [Mainz Pain Staging System] |
100033-0 | http://loinc.org | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] |
100034-8 | http://loinc.org | Provider of automated external defibrillator use |
100035-5 | http://loinc.org | Exam finding location of Chest |
100036-3 | http://loinc.org | Exam finding location of Lung |
100037-1 | http://loinc.org | Patient contact disposition EMS unit |
100038-9 | http://loinc.org | Patient evaluation disposition EMS unit |
100039-7 | http://loinc.org | Crew disposition for patient care EMS unit |
10004-0 | http://loinc.org | R wave duration in lead V1 |
100040-5 | http://loinc.org | Patient transport disposition EMS unit |
100041-3 | http://loinc.org | Aminoglycoside [Susceptibility] |
100042-1 | http://loinc.org | Atovaquone [Susceptibility] |
100043-9 | http://loinc.org | Azithromycin+Ethambutol [Susceptibility] |
100044-7 | http://loinc.org | Cefcapene [Susceptibility] |
100045-4 | http://loinc.org | Cefozopran [Susceptibility] |
100046-2 | http://loinc.org | Cefquinome [Susceptibility] |
100047-0 | http://loinc.org | Cefteram [Susceptibility] |
100048-8 | http://loinc.org | Clarithromycin+Ethambutol [Susceptibility] |
100049-6 | http://loinc.org | Eravacycline [Susceptibility] |
100050-4 | http://loinc.org | Erythromycin+Ethambutol [Susceptibility] |
100051-2 | http://loinc.org | Ethambutol+rifAMPin [Susceptibility] |
100052-0 | http://loinc.org | Flomoxef [Susceptibility] |
100053-8 | http://loinc.org | Fluoroquinolone [Susceptibility] |
100054-6 | http://loinc.org | Gamithromycin [Susceptibility] |
100055-3 | http://loinc.org | Optochin [Susceptibility] |
100056-1 | http://loinc.org | Panipenem [Susceptibility] |
10005-7 | http://loinc.org | R wave duration in lead V2 |
100057-9 | http://loinc.org | Prothionamide [Susceptibility] |
100058-7 | http://loinc.org | Prulifloxacin [Susceptibility] |
100059-5 | http://loinc.org | Rifapentine [Susceptibility] |
100060-3 | http://loinc.org | Tildipirosin [Susceptibility] |
100061-1 | http://loinc.org | Tosufloxacin [Susceptibility] |
100062-9 | http://loinc.org | Standard Dermatology Outcome Measures panel |
100063-7 | http://loinc.org | Primary skin concern |
100064-5 | http://loinc.org | Itch severity Reporting Period - Reported |
10006-5 | http://loinc.org | R wave duration in lead V3 |
100065-2 | http://loinc.org | Satisfied with treatment |
100066-0 | http://loinc.org | Specular microscopy panel |
100067-8 | http://loinc.org | Eye Image magnification |
100068-6 | http://loinc.org | Right eye Fixation point [Angle] |
100069-4 | http://loinc.org | Left eye Fixation point [Angle] |
100070-2 | http://loinc.org | Right cornea Cell density |
100071-0 | http://loinc.org | Left cornea Cell density |
100072-8 | http://loinc.org | Right cornea Coefficient of variation |
10007-3 | http://loinc.org | R wave duration in lead V4 |
100073-6 | http://loinc.org | Left cornea Coefficient of variation |
100074-4 | http://loinc.org | Right cornea Hexagonality |
100075-1 | http://loinc.org | Left cornea Hexagonality |
100076-9 | http://loinc.org | Right cornea Endothelial cells counted |
100077-7 | http://loinc.org | Left cornea Endothelial cells counted |
100078-5 | http://loinc.org | Right cornea Endothelial cell area.min |
100079-3 | http://loinc.org | Left cornea Endothelial cell area.min |
100080-1 | http://loinc.org | Right cornea Endothelial cell area.max |
10008-1 | http://loinc.org | R wave duration in lead V5 |
100081-9 | http://loinc.org | Left cornea Endothelial cell area.max |
100082-7 | http://loinc.org | Right cornea Endothelial cell area.mean |
100083-5 | http://loinc.org | Left cornea Endothelial cell area.mean |
100084-3 | http://loinc.org | Right cornea Cell area.standard deviation |
100085-0 | http://loinc.org | Left cornea Cell area.standard deviation |
100086-8 | http://loinc.org | Right cornea Type of Analysis method by Specular microscopy |
100087-6 | http://loinc.org | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot |
100088-4 | http://loinc.org | Taenia solium larva Ab bands panel - Serum by Immunoblot |
100089-2 | http://loinc.org | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot |
1000-9 | http://loinc.org | DBG Ab [Presence] in Serum or Plasma from Blood product unit |
100090-0 | http://loinc.org | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot |
100091-8 | http://loinc.org | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay |
100092-6 | http://loinc.org | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot |
100093-4 | http://loinc.org | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot |
100094-2 | http://loinc.org | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot |
100095-9 | http://loinc.org | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
100096-7 | http://loinc.org | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot |
100097-5 | http://loinc.org | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot |
100098-3 | http://loinc.org | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot |
10009-9 | http://loinc.org | R wave duration in lead V6 |
100099-1 | http://loinc.org | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot |
100100-7 | http://loinc.org | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay |
100101-5 | http://loinc.org | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot |
100102-3 | http://loinc.org | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
100103-1 | http://loinc.org | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot |
100104-9 | http://loinc.org | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot |
100105-6 | http://loinc.org | Filaria IgG and IgM panel - Serum |
100106-4 | http://loinc.org | Filaria IgG Ab [Presence] in Serum by Immunoassay |
10010-7 | http://loinc.org | R' wave amplitude in lead AVF |
100107-2 | http://loinc.org | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay |
100108-0 | http://loinc.org | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay |
100109-8 | http://loinc.org | Leishmania sp Ab bands panel - Serum by Immunoblot |
100110-6 | http://loinc.org | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot |
100111-4 | http://loinc.org | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot |
100112-2 | http://loinc.org | Fasciola sp Ab bands panel - Serum by Immunoblot |
100113-0 | http://loinc.org | Helicobacter pylori Ab panel - Serum |
100114-8 | http://loinc.org | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot |
10011-5 | http://loinc.org | R' wave amplitude in lead AVL |
100115-5 | http://loinc.org | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot |
100116-3 | http://loinc.org | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot |
100117-1 | http://loinc.org | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot |
100118-9 | http://loinc.org | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot |
100119-7 | http://loinc.org | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot |
100120-5 | http://loinc.org | Chlamydia trachomatis Ab panel - Serum |
100121-3 | http://loinc.org | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay |
100122-1 | http://loinc.org | Chlamydophila pneumoniae Ab panel - Serum |
10012-3 | http://loinc.org | R' wave amplitude in lead AVR |
100123-9 | http://loinc.org | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay |
100124-7 | http://loinc.org | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay |
100125-4 | http://loinc.org | Chlamydophila psittaci Ab panel - Serum |
100126-2 | http://loinc.org | Bordetella pertussis Ab.IgG panel - Serum |
100127-0 | http://loinc.org | Campylobacter sp Ab panel - Serum |
100128-8 | http://loinc.org | Cryptococcus sp Ag panel - Serum |
100129-6 | http://loinc.org | Schistosoma sp Ab [Titer] in Serum by Hemagglutination |
100130-4 | http://loinc.org | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot |
10013-1 | http://loinc.org | R' wave amplitude in lead I |
100131-2 | http://loinc.org | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot |
100132-0 | http://loinc.org | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot |
100133-8 | http://loinc.org | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot |
100134-6 | http://loinc.org | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot |
100135-3 | http://loinc.org | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot |
100136-1 | http://loinc.org | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot |
100137-9 | http://loinc.org | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot |
100138-7 | http://loinc.org | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot |
100139-5 | http://loinc.org | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot |
100140-3 | http://loinc.org | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot |
100141-1 | http://loinc.org | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot |
100142-9 | http://loinc.org | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot |
100143-7 | http://loinc.org | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot |
100144-5 | http://loinc.org | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot |
100145-2 | http://loinc.org | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot |
100146-0 | http://loinc.org | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot |
100147-8 | http://loinc.org | Toxoplasma gondii Ab bands panel - Serum by Immunoblot |
100148-6 | http://loinc.org | Schistosoma sp Ab bands panel - Serum by Immunoblot |
10014-9 | http://loinc.org | R' wave amplitude in lead II |
100149-4 | http://loinc.org | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma |
100150-2 | http://loinc.org | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma |
100151-0 | http://loinc.org | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma |
100152-8 | http://loinc.org | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
100153-6 | http://loinc.org | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
100154-4 | http://loinc.org | Specimen collection supervision level |
100155-1 | http://loinc.org | Left cornea Type of Analysis method by Specular microscopy |
10015-6 | http://loinc.org | R' wave amplitude in lead III |
100156-9 | http://loinc.org | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection |
100157-7 | http://loinc.org | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing |
100158-5 | http://loinc.org | Microalbumin [Mass/volume] in Urine collected for unspecified duration |
100159-3 | http://loinc.org | Knee Society Score pre-op panel [Knee Society Score] |
100160-1 | http://loinc.org | Knee replacement |
100161-9 | http://loinc.org | Charnley Functional Classification |
100162-7 | http://loinc.org | Knee alignment W standing X-ray measured |
100163-5 | http://loinc.org | Knee medial AndOr lateral instability W full extension |
10016-4 | http://loinc.org | R' wave amplitude in lead V1 |
100164-3 | http://loinc.org | Knee AP instability W 90 degree flexion |
100165-0 | http://loinc.org | Knee range of motion |
100166-8 | http://loinc.org | Flexion contracture range of Knee |
100167-6 | http://loinc.org | Extensor lag range of Knee |
100168-4 | http://loinc.org | Knee pain severity with level walking |
100169-2 | http://loinc.org | Knee pain severity with stairs or inclines |
1001-7 | http://loinc.org | DBG Ab [Presence] in Serum or Plasma from Donor |
100170-0 | http://loinc.org | Knee feels normal |
100171-8 | http://loinc.org | Satisfaction with level of knee pain while sitting |
10017-2 | http://loinc.org | R' wave amplitude in lead V2 |
100172-6 | http://loinc.org | Satisfaction with level of knee pain while lying in bed |
100173-4 | http://loinc.org | Satisfaction with knee function while getting out of bed |
100174-2 | http://loinc.org | Satisfaction with knee function while performing light household duties |
100175-9 | http://loinc.org | Satisfaction with knee function while performing recreational activities |
100176-7 | http://loinc.org | Expect surgery to relieve pain |
100177-5 | http://loinc.org | Expect surgery will improve ability to perform activities of daily living |
100178-3 | http://loinc.org | Expect surgery will improve ability to perform leisure, recreational, or sports activities |
100179-1 | http://loinc.org | Walk without assistive mobility devices |
10018-0 | http://loinc.org | R' wave amplitude in lead V3 |
100180-9 | http://loinc.org | Assistive mobility devices used |
100181-7 | http://loinc.org | Assistive mobility devices used due to health condition |
100182-5 | http://loinc.org | Duration of standing before sitting due to knee discomfort |
100183-3 | http://loinc.org | Duration of walking before stopping due to knee discomfort |
100184-1 | http://loinc.org | How bothersome is knee when walking on an uneven surface |
100185-8 | http://loinc.org | How bothersome is knee when turning or pivoting leg |
100186-6 | http://loinc.org | How bothersome is knee when climbing up or down a flight of stairs |
100187-4 | http://loinc.org | How bothersome is knee when getting up from a low seat without armrests |
100188-2 | http://loinc.org | How bothersome is knee when getting into or out of a car |
100189-0 | http://loinc.org | How bothersome is knee when moving laterally |
100190-8 | http://loinc.org | How bothersome is knee when climbing a ladder or step stool |
100191-6 | http://loinc.org | How bothersome is knee when carrying a bag for one block |
100192-4 | http://loinc.org | How bothersome is knee when squatting |
100193-2 | http://loinc.org | How bothersome is knee when kneeling |
100194-0 | http://loinc.org | How bothersome is knee when running |
100195-7 | http://loinc.org | Pain severity--during activity |
100196-5 | http://loinc.org | Pre-op total score [Knee Society Score] |
100197-3 | http://loinc.org | Exercise activity and pain severity panel |
10019-8 | http://loinc.org | R' wave amplitude in lead V4 |
100198-1 | http://loinc.org | Pre-op objective knee indicators score [Knee Society Score] |
100199-9 | http://loinc.org | Pre-op symptoms score [Knee Society Score] |
100200-5 | http://loinc.org | Pre-op patient expectations score [Knee Society Score] |
100201-3 | http://loinc.org | Pre-op functional activities score [Knee Society Score] |
100202-1 | http://loinc.org | Pre-op discretionary knee activities score [Knee Society Score] |
100203-9 | http://loinc.org | Knee Society Score post-op panel [Knee Society Score] |
100204-7 | http://loinc.org | Accuracy of pre-surgery expectations of pain relief |
100205-4 | http://loinc.org | Accuracy of pre-surgery expectations to perform activities of daily living |
10020-6 | http://loinc.org | R' wave amplitude in lead V5 |
100206-2 | http://loinc.org | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities |
100207-0 | http://loinc.org | Post-op total score [Knee Society Score] |
100208-8 | http://loinc.org | Post-op objective knee indicators score [Knee Society Score] |
100209-6 | http://loinc.org | Post-op symptoms score [Knee Society Score] |
100210-4 | http://loinc.org | Post-op patient expectations score [Knee Society Score] |
100211-2 | http://loinc.org | Post-op functional activities score [Knee Society Score] |
100212-0 | http://loinc.org | Post-op discretionary knee activities score [Knee Society Score] |
100213-8 | http://loinc.org | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method |
10021-4 | http://loinc.org | R' wave amplitude in lead V6 |
100214-6 | http://loinc.org | Dental model prior authorization Document |
100215-3 | http://loinc.org | Episode of care medical records Document Transplant surgery |
100216-1 | http://loinc.org | Surgical synoptic report |
100217-9 | http://loinc.org | Synoptic report Narrative Surgical oncology |
100218-7 | http://loinc.org | Surgical oncology of colon cancer synoptic report |
100219-5 | http://loinc.org | Surgical oncology of melanoma cancer synoptic report |
100220-3 | http://loinc.org | Surgical oncology of breast cancer synoptic report |
100221-1 | http://loinc.org | Surgical oncology of thyroid cancer synoptic report |
10022-2 | http://loinc.org | R' wave duration in lead AVF |
100222-9 | http://loinc.org | Surgical oncology of pancreas cancer synoptic report |
100223-7 | http://loinc.org | Physical findings of Retina Narrative |
100224-5 | http://loinc.org | Cardiac left ventricular segmental wall motion by echo panel |
100225-2 | http://loinc.org | Bone density quantitative ultrasound study |
100226-0 | http://loinc.org | Small bowel capsule endoscopy study Document |
100227-8 | http://loinc.org | Colon capsule endoscopy study Document |
100228-6 | http://loinc.org | Upper gastrointestinal capsule endoscopy study Document |
100229-4 | http://loinc.org | Endoscopic ultrasound study Document |
10023-0 | http://loinc.org | R' wave duration in lead AVL |
100230-2 | http://loinc.org | Routine prenatal assessment panel |
100231-0 | http://loinc.org | Endobronchial ultrasound study |
100232-8 | http://loinc.org | Impacts of Events Scale-Revised panel |
100233-6 | http://loinc.org | Reminders brought back feelings about adverse event |
100234-4 | http://loinc.org | Trouble staying asleep |
100235-1 | http://loinc.org | Other things triggered persistent thoughts about adverse event |
100236-9 | http://loinc.org | Felt irritable AndOr angry |
100237-7 | http://loinc.org | Avoided getting upset when unintentionally thought about adverse event |
100238-5 | http://loinc.org | Thought about adverse event unintentionally |
100239-3 | http://loinc.org | Felt as if adverse event did not happen |
100240-1 | http://loinc.org | Avoided reminders of adverse event |
100241-9 | http://loinc.org | Experienced mental images of adverse event |
100242-7 | http://loinc.org | Easily startled |
100243-5 | http://loinc.org | Tried to not think of adverse event |
100244-3 | http://loinc.org | Aware of feelings about adverse event, but did not address them |
100245-0 | http://loinc.org | Feelings about adverse event were numb |
100246-8 | http://loinc.org | Acted or felt the same as during adverse event |
100247-6 | http://loinc.org | Trouble falling asleep |
10024-8 | http://loinc.org | R' wave duration in lead AVR |
100248-4 | http://loinc.org | Waves of strong feelings about adverse event |
100249-2 | http://loinc.org | Tried to remove adverse event from memory |
1002-5 | http://loinc.org | DBG Ab [Presence] in Serum or Plasma |
100250-0 | http://loinc.org | Trouble concentrating |
100251-8 | http://loinc.org | Reminders of adverse event caused physical reactions |
100252-6 | http://loinc.org | Had dreams about adverse event |
100253-4 | http://loinc.org | Felt watchful and on-guard |
100254-2 | http://loinc.org | Tried not to talk about adverse event |
10025-5 | http://loinc.org | R' wave duration in lead I |
100255-9 | http://loinc.org | Total score [Impact of Event Scale-Revised] |
100256-7 | http://loinc.org | Fallen in last 6 months |
100257-5 | http://loinc.org | Feel unsteady when standing or walking |
100258-3 | http://loinc.org | History of fall related injury |
100259-1 | http://loinc.org | Aware of tactile sensations |
100260-9 | http://loinc.org | Easy to describe thoughts AndOr feelings |
100261-7 | http://loinc.org | Critical of own thoughts AndOr feelings |
100262-5 | http://loinc.org | Able to notice distressing thoughts AndOr feelings without having to react |
10026-3 | http://loinc.org | R' wave duration in lead II |
100263-3 | http://loinc.org | Easily distracted |
100264-1 | http://loinc.org | Able to notice thoughts AndOr feelings without being overwhelmed |
100265-8 | http://loinc.org | Aware of dietary intake impact on self |
100266-6 | http://loinc.org | Difficult to describe thoughts AndOr feelings |
100267-4 | http://loinc.org | Aware of auditory stimuli |
100268-2 | http://loinc.org | Able to avoid immediate reaction in difficult situations |
100269-0 | http://loinc.org | Do things without paying attention |
100270-8 | http://loinc.org | Recover quickly from distressing thoughts AndOr images |
10027-1 | http://loinc.org | R' wave duration in lead III |
100271-6 | http://loinc.org | Aware of olfactory stimuli |
100272-4 | http://loinc.org | Aware of visual stimuli |
100273-2 | http://loinc.org | Aware of emotions affect on thoughts AndOr behavior |
100274-0 | http://loinc.org | Observing score [FFMQ] |
100275-7 | http://loinc.org | Describing score [FFMQ] |
100276-5 | http://loinc.org | Acting with awareness score [FFMQ] |
100277-3 | http://loinc.org | Nonjudging score [FFMQ] |
100278-1 | http://loinc.org | Nonreactivity score [FFMQ] |
100279-9 | http://loinc.org | Total score [FFMQ] |
100280-7 | http://loinc.org | Five Facet Mindfulness Questionnaire panel [FFMQ] |
100281-5 | http://loinc.org | D Ab [Units/volume] in Serum or Plasma |
100282-3 | http://loinc.org | Vaccine exemption certificate |
100283-1 | http://loinc.org | Harris Hip Score panel [Harris Hip Score] |
100284-9 | http://loinc.org | Walking - functional ability |
100285-6 | http://loinc.org | Comfortable seated position |
100286-4 | http://loinc.org | Able to board public transportation |
100287-2 | http://loinc.org | Put on shoes and socks |
100288-0 | http://loinc.org | Absence of deformity score [Harris Hip Score] |
10028-9 | http://loinc.org | R' wave duration in lead V1 |
100289-8 | http://loinc.org | Absence of hip deformity measurements |
100290-6 | http://loinc.org | Range of motion score [Harris Hip Score] |
100291-4 | http://loinc.org | Total score [Harris Hip Score] |
100292-2 | http://loinc.org | Pre-op patient satisfaction score [Knee Society Score] |
100293-0 | http://loinc.org | Hip Flexion range of motion |
100294-8 | http://loinc.org | Hip Abduction range of motion |
100295-5 | http://loinc.org | Hip Adduction range of motion |
100296-3 | http://loinc.org | Hip External rotation range of motion |
10029-7 | http://loinc.org | R' wave duration in lead V2 |
100297-1 | http://loinc.org | Hip Internal rotation range of motion |
100298-9 | http://loinc.org | Repetition count |
100299-7 | http://loinc.org | Post-op patient satisfaction score [Knee Society Score] |
100300-3 | http://loinc.org | End time Unspecified body region |
100301-1 | http://loinc.org | Start time Unspecified body region |
100302-9 | http://loinc.org | Time period start and end panel Unspecified body region |
100303-7 | http://loinc.org | Condition certainty of presence |
100304-5 | http://loinc.org | Flights climbed [#] Reporting Period |
10030-5 | http://loinc.org | R' wave duration in lead V3 |
100305-2 | http://loinc.org | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |
100306-0 | http://loinc.org | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |
100307-8 | http://loinc.org | Behavioral screening elder mistreatment |
100308-6 | http://loinc.org | Need help getting to essential places |
100309-4 | http://loinc.org | Activity support person |
100310-2 | http://loinc.org | Reliability of support person |
100311-0 | http://loinc.org | Need help to make sure there is enough food, medicines or any other things needed in house |
100312-8 | http://loinc.org | Person or persons that makes sure there is enough food, medicines or any other things needed in house |
10031-3 | http://loinc.org | R' wave duration in lead V4 |
100313-6 | http://loinc.org | Need help with household things such as cook meals, help feed, or provide correct medicines each day |
100314-4 | http://loinc.org | Need help with house cleaning or yard work |
100315-1 | http://loinc.org | Need help getting out of bed, showered, or dressed |
100316-9 | http://loinc.org | Need help to make sure bills get paid |
100317-7 | http://loinc.org | Relationship of usual support person for daily activities |
100318-5 | http://loinc.org | Have help with finances AndOr financial decisions |
100319-3 | http://loinc.org | Relationship of financial support person |
100320-1 | http://loinc.org | Financial support person usually asks for permission before making decisions |
10032-1 | http://loinc.org | R' wave duration in lead V5 |
100321-9 | http://loinc.org | Financial support person usually makes good decisions about finances |
100322-7 | http://loinc.org | Have access to paperwork for financial decisions made |
100323-5 | http://loinc.org | Financial support person forged signature |
100324-3 | http://loinc.org | Coercion of financial support person for signing a document in order to get money or possessions |
100325-0 | http://loinc.org | Experienced theft by support person |
100326-8 | http://loinc.org | Money spent or property sold without permission |
100327-6 | http://loinc.org | Stranger forged signature for financial gain |
100328-4 | http://loinc.org | Stranger forced document signature for financial gain |
100329-2 | http://loinc.org | Feared for safety due to verbal attack |
1003-3 | http://loinc.org | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
100330-0 | http://loinc.org | Felt humiliated due to ridicule |
100331-8 | http://loinc.org | Coerced to do something |
100332-6 | http://loinc.org | Ignored by close friend or relative for extended period |
100333-4 | http://loinc.org | Physically hit or threatened |
100334-2 | http://loinc.org | Been physically hurt with some degree of injury |
100335-9 | http://loinc.org | Coerced sexual activity |
100336-7 | http://loinc.org | Coerced touching of private body parts of self or others |
100337-5 | http://loinc.org | Coerced to undress or expose private body area |
100338-3 | http://loinc.org | Photographed in any degree of nudity without consent |
10033-9 | http://loinc.org | R' wave duration in lead V6 |
100339-1 | http://loinc.org | Experienced attempted physical restraint |
100340-9 | http://loinc.org | Range of motion panel Hip |
100341-7 | http://loinc.org | Rubella virus IgG Ab index [Units/volume] in Serum and CSF |
100342-5 | http://loinc.org | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry |
100343-3 | http://loinc.org | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
100344-1 | http://loinc.org | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
100345-8 | http://loinc.org | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection |
100346-6 | http://loinc.org | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG |
10034-7 | http://loinc.org | S wave amplitude in lead AVF |
100347-4 | http://loinc.org | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG |
100348-2 | http://loinc.org | Model for end-stage liver disease sodium score |
100349-0 | http://loinc.org | US.doppler Penis vessels W vasodilator IV |
100350-8 | http://loinc.org | Sesamum indicum 1 IgE Ab [Units/volume] in Serum |
100351-6 | http://loinc.org | Pioglitazone [Presence] in Serum or Plasma |
100352-4 | http://loinc.org | Rosiglitazone [Presence] in Serum or Plasma |
100353-2 | http://loinc.org | Norwalk Community Health Center Screening Tool [NCHC] |
10035-4 | http://loinc.org | S wave amplitude in lead AVL |
100354-0 | http://loinc.org | Frequency of participating in multi-modal communication without assistance |
100355-7 | http://loinc.org | Frequency of participating in spoken language expression communication without assistance |
100356-5 | http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection |
100357-3 | http://loinc.org | Naloxone [Presence] in Cord tissue by Screen method |
100358-1 | http://loinc.org | Phentermine [Presence] in Cord tissue by Screen method |
100359-9 | http://loinc.org | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay |
100360-7 | http://loinc.org | Brief Resilience Scale panel [BRS] |
100361-5 | http://loinc.org | Quickly recover from bad events |
10036-2 | http://loinc.org | S wave amplitude in lead AVR |
100362-3 | http://loinc.org | Difficulty making it through stressful events |
100363-1 | http://loinc.org | Easily recover from a stressful event |
100364-9 | http://loinc.org | Difficulty recovering from bad events |
100365-6 | http://loinc.org | Easily recover from difficulties |
100366-4 | http://loinc.org | Lengthy recovery from setbacks |
100367-2 | http://loinc.org | Total Score BRS |
100368-0 | http://loinc.org | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS |
100369-8 | http://loinc.org | NM Thyroid gland Views W Tl-201 IV |
10037-0 | http://loinc.org | S wave amplitude in lead I |
100370-6 | http://loinc.org | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection |
100371-4 | http://loinc.org | Titin Ab [Units/volume] in Serum by Immunoassay |
100372-2 | http://loinc.org | Abiraterone [Mass/volume] in Serum or Plasma |
100373-0 | http://loinc.org | Eucheuma IgG Ab [Units/volume] in Serum |
100374-8 | http://loinc.org | Aloe vera IgG Ab [Units/volume] in Serum |
100375-5 | http://loinc.org | Anise IgG Ab [Units/volume] in Serum |
100376-3 | http://loinc.org | Bambusa vulgaris IgG Ab [Units/volume] in Serum |
100377-1 | http://loinc.org | Goat cheese IgG Ab [Units/volume] in Serum |
100378-9 | http://loinc.org | Sheep cheese IgG Ab [Units/volume] in Serum |
100379-7 | http://loinc.org | Leeks IgG Ab [Units/volume] in Serum |
100380-5 | http://loinc.org | Red cabbage IgG Ab [Units/volume] in Serum |
100381-3 | http://loinc.org | Mentha balsamea Wild IgG Ab [Units/volume] in Serum |
100382-1 | http://loinc.org | FDA package insert REMS addressed risk |
100383-9 | http://loinc.org | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection |
100384-7 | http://loinc.org | Rapeseed IgG Ab [Units/volume] in Serum |
100385-4 | http://loinc.org | Corn salad IgG Ab [Units/volume] in Serum |
100386-2 | http://loinc.org | Rosemary IgG Ab [Units/volume] in Serum |
100387-0 | http://loinc.org | Poppy Seed IgG Ab [Units/volume] in Serum |
10038-8 | http://loinc.org | S wave amplitude in lead II |
100388-8 | http://loinc.org | Cocoa IgG Ab [Units/volume] in Serum |
100389-6 | http://loinc.org | Pistachio IgG Ab [Units/volume] in Serum |
100390-4 | http://loinc.org | Sunflower Seed IgG Ab [Units/volume] in Serum |
100391-2 | http://loinc.org | Dates IgG Ab [Units/volume] in Serum |
100392-0 | http://loinc.org | Duck meat IgG Ab [Units/volume] in Serum |
100393-8 | http://loinc.org | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum |
100394-6 | http://loinc.org | Astacoidea IgG Ab [Units/volume] in Serum |
100395-3 | http://loinc.org | Carob IgG Ab [Units/volume] in Serum |
10039-6 | http://loinc.org | S wave amplitude in lead III |
100396-1 | http://loinc.org | Brassica napus IgG Ab [Units/volume] in Serum |
100397-9 | http://loinc.org | Goat Meat IgG Ab [Units/volume] in Serum |
100398-7 | http://loinc.org | Goose meat IgG Ab [Units/volume] in Serum |
100399-5 | http://loinc.org | Ostrich meat IgG Ab [Units/volume] in Serum |
100400-1 | http://loinc.org | Quail meat IgG Ab [Units/volume] in Serum |
100401-9 | http://loinc.org | Rabbit meat IgG Ab [Units/volume] in Serum |
100402-7 | http://loinc.org | Venison meat IgG Ab [Units/volume] in Serum |
100403-5 | http://loinc.org | Guineafowl IgG Ab [Units/volume] in Serum |
10040-4 | http://loinc.org | S wave amplitude in lead V1 |
100404-3 | http://loinc.org | Horse meat IgG Ab [Units/volume] in Serum |
100405-0 | http://loinc.org | Kefir IgG Ab [Units/volume] in Serum |
100406-8 | http://loinc.org | Butter IgG Ab [Units/volume] in Serum |
100407-6 | http://loinc.org | Camembert cheese IgG Ab [Units/volume] in Serum |
100408-4 | http://loinc.org | Emmental cheese IgG Ab [Units/volume] in Serum |
100409-2 | http://loinc.org | Processed cheese IgG Ab [Units/volume] in Serum |
1004-1 | http://loinc.org | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
100410-0 | http://loinc.org | Curd cheese IgG Ab [Units/volume] in Serum |
100411-8 | http://loinc.org | Sugar Beet IgG Ab [Units/volume] in Serum |
10041-2 | http://loinc.org | S wave amplitude in lead V2 |
100412-6 | http://loinc.org | Chinese cabbage IgG Ab [Units/volume] in Serum |
100413-4 | http://loinc.org | Fennel Fresh IgG Ab [Units/volume] in Serum |
100414-2 | http://loinc.org | Gourd IgG Ab [Units/volume] in Serum |
100415-9 | http://loinc.org | Kale IgG Ab [Units/volume] in Serum |
100416-7 | http://loinc.org | Savoy cabbage IgG Ab [Units/volume] in Serum |
100417-5 | http://loinc.org | Vitis sp leaf IgG Ab [Units/volume] in Serum |
100418-3 | http://loinc.org | Liquorice IgG Ab [Units/volume] in Serum |
100419-1 | http://loinc.org | Snow pea IgG Ab [Units/volume] in Serum |
10042-0 | http://loinc.org | S wave amplitude in lead V3 |
100420-9 | http://loinc.org | Fava bean IgG Ab [Units/volume] in Serum |
100421-7 | http://loinc.org | Chick Pea IgG Ab [Units/volume] in Serum |
100422-5 | http://loinc.org | Chicory IgG Ab [Units/volume] in Serum |
100423-3 | http://loinc.org | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum |
100424-1 | http://loinc.org | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma |
100425-8 | http://loinc.org | DiHydro T-Mas [Mass/volume] in Serum or Plasma |
100426-6 | http://loinc.org | Squalene [Mass/volume] in Serum or Plasma |
100427-4 | http://loinc.org | Stigmasterol [Mass/volume] in Serum or Plasma |
100428-2 | http://loinc.org | Carnitine free and total and acylcarnitine panel - Urine |
100429-0 | http://loinc.org | LRBA deficiency panel - Blood |
100430-8 | http://loinc.org | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) |
100431-6 | http://loinc.org | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |
100432-4 | http://loinc.org | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) |
100433-2 | http://loinc.org | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |
100434-0 | http://loinc.org | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection |
100435-7 | http://loinc.org | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay |
100436-5 | http://loinc.org | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay |
100437-3 | http://loinc.org | Norsufentanil [Mass/volume] in Urine by Confirmatory method |
10043-8 | http://loinc.org | S wave amplitude in lead V4 |
100438-1 | http://loinc.org | Adolescent medicine Outpatient Progress note |
100439-9 | http://loinc.org | Allergy and Immunology Outpatient Progress note |
100440-7 | http://loinc.org | Allergy Outpatient Progress note |
100441-5 | http://loinc.org | Attending Outpatient Progress note |
100442-3 | http://loinc.org | Audiology Outpatient Progress note |
100443-1 | http://loinc.org | Bariatric surgery Outpatient Progress note |
100444-9 | http://loinc.org | Blood banking and transfusion medicine Outpatient Progress note |
100445-6 | http://loinc.org | Bone Marrow Transplant Outpatient Progress note |
10044-6 | http://loinc.org | S wave amplitude in lead V5 |
100446-4 | http://loinc.org | Breastfeeding Outpatient Progress note |
100447-2 | http://loinc.org | Burn management Outpatient Progress note |
100448-0 | http://loinc.org | Cardiac surgery Outpatient Progress note |
100449-8 | http://loinc.org | Cardiopulmonary Outpatient Progress note |
100450-6 | http://loinc.org | Child and adolescent psychiatry Outpatient Progress note |
100451-4 | http://loinc.org | Chiropractic medicine Outpatient Progress note |
100452-2 | http://loinc.org | Clinical cardiac electrophysiology Outpatient Progress note |
10045-3 | http://loinc.org | S wave amplitude in lead V6 |
100453-0 | http://loinc.org | Clinical genetics Outpatient Progress note |
100454-8 | http://loinc.org | Clinical neurophysiology Outpatient Progress note |
100455-5 | http://loinc.org | Clinical pathology Outpatient Progress note |
100456-3 | http://loinc.org | Colon and rectal surgery Outpatient Progress note |
100457-1 | http://loinc.org | Consultant Outpatient Progress note |
100458-9 | http://loinc.org | Outpatient COVID-19 Intubation Progress note |
100459-7 | http://loinc.org | Outpatient COVID-19 Progress note |
100460-5 | http://loinc.org | Dermatology Outpatient Progress note |
10046-1 | http://loinc.org | S wave duration in lead AVF |
100461-3 | http://loinc.org | Developmental-behavioral pediatrics Outpatient Progress note |
100462-1 | http://loinc.org | Dialysis and Therapeutic apheresis Outpatient Progress note |
100463-9 | http://loinc.org | Eating disorders Outpatient Progress note |
100464-7 | http://loinc.org | Endocrinology Outpatient Progress note |
100465-4 | http://loinc.org | Family medicine Outpatient Progress note |
100466-2 | http://loinc.org | Gastroenterology Outpatient Progress note |
100467-0 | http://loinc.org | Geriatric medicine Outpatient Progress note |
100468-8 | http://loinc.org | Gynecologic oncology Outpatient Progress note |
100469-6 | http://loinc.org | Gynecology Outpatient Progress note |
100470-4 | http://loinc.org | Healthcare navigator Outpatient Progress note |
100471-2 | http://loinc.org | Heart failure Outpatient Progress note |
100472-0 | http://loinc.org | Heart failure+Transplant cardiology Outpatient Progress note |
100473-8 | http://loinc.org | Hematology Outpatient Progress note |
100474-6 | http://loinc.org | Hematology+Medical oncology Outpatient Progress note |
100475-3 | http://loinc.org | Hepatology Outpatient Progress note |
100476-1 | http://loinc.org | Immunology Outpatient Progress note |
100477-9 | http://loinc.org | Infectious disease Outpatient Progress note |
100478-7 | http://loinc.org | Internal medicine Outpatient Progress note |
10047-9 | http://loinc.org | S wave duration in lead AVL |
100479-5 | http://loinc.org | Interventional cardiology Outpatient Progress note |
100480-3 | http://loinc.org | Interventional radiology Outpatient Progress note |
100481-1 | http://loinc.org | Outpatient Mechanical circulatory support Progress note |
100482-9 | http://loinc.org | Medical Aid in Dying Outpatient Progress note |
100483-7 | http://loinc.org | Mental health Outpatient Progress note |
100484-5 | http://loinc.org | Multi-specialty program Outpatient Progress note |
100485-2 | http://loinc.org | Neonatal perinatal medicine Outpatient Progress note |
100486-0 | http://loinc.org | Nephrology Outpatient Progress note |
10048-7 | http://loinc.org | S wave duration in lead AVR |
100487-8 | http://loinc.org | Neurological surgery Outpatient Progress note |
100488-6 | http://loinc.org | Neurology Outpatient Progress note |
100489-4 | http://loinc.org | Neurology with special qualifications in child neurology Outpatient Progress note |
100490-2 | http://loinc.org | Nurse practitioner Outpatient Progress note |
100491-0 | http://loinc.org | Nurse Outpatient Progress note |
100492-8 | http://loinc.org | Nutrition and dietetics Outpatient Progress note |
100493-6 | http://loinc.org | Obstetrics and Gynecology Outpatient Progress note |
100494-4 | http://loinc.org | Obstetrics Outpatient Progress note |
10049-5 | http://loinc.org | S wave duration in lead I |
100495-1 | http://loinc.org | Occupational therapy Outpatient Progress note |
100496-9 | http://loinc.org | Oncology Outpatient Progress note |
100497-7 | http://loinc.org | Ophthalmology Outpatient Progress note |
100498-5 | http://loinc.org | Optometry Outpatient Progress note |
100499-3 | http://loinc.org | Oral and Maxillofacial Surgery Outpatient Progress note |
100500-8 | http://loinc.org | Orthopaedic surgery Outpatient Progress note |
100501-6 | http://loinc.org | Orthotics prosthetics Outpatient Progress note |
100502-4 | http://loinc.org | Otolaryngology Outpatient Progress note |
10050-3 | http://loinc.org | S wave duration in lead II |
100503-2 | http://loinc.org | Pain medicine Outpatient Progress note |
100504-0 | http://loinc.org | Palliative care Outpatient Progress note |
100505-7 | http://loinc.org | Pediatric cardiology Outpatient Progress note |
100506-5 | http://loinc.org | Pediatric dermatology Outpatient Progress note |
100507-3 | http://loinc.org | Pediatric endocrinology Outpatient Progress note |
100508-1 | http://loinc.org | Pediatric gastroenterology Outpatient Progress note |
100509-9 | http://loinc.org | Pediatric hematology-oncology Outpatient Progress note |
100510-7 | http://loinc.org | Pediatric infectious diseases Outpatient Progress note |
10051-1 | http://loinc.org | S wave duration in lead III |
100511-5 | http://loinc.org | Pediatric otolaryngology Outpatient Progress note |
100512-3 | http://loinc.org | Pediatric pulmonology Outpatient Progress note |
100513-1 | http://loinc.org | Pediatric rheumatology Outpatient Progress note |
100514-9 | http://loinc.org | Pediatric surgery Outpatient Progress note |
100515-6 | http://loinc.org | Pediatric transplant hepatology Outpatient Progress note |
100516-4 | http://loinc.org | Pediatric urology Outpatient Progress note |
100517-2 | http://loinc.org | Pharmacogenomics Outpatient Progress note |
100518-0 | http://loinc.org | Physical medicine and rehab Outpatient Progress note |
100519-8 | http://loinc.org | Physical therapy Outpatient Progress note |
100520-6 | http://loinc.org | Plastic surgery Outpatient Progress note |
100521-4 | http://loinc.org | Podiatry Outpatient Progress note |
100522-2 | http://loinc.org | Psychiatry Hospital Progress note |
100523-0 | http://loinc.org | Psychology Outpatient Progress note |
100524-8 | http://loinc.org | Pulmonary Outpatient Progress note |
100525-5 | http://loinc.org | Radiation oncology Outpatient Progress note |
100526-3 | http://loinc.org | Radiology Outpatient Progress note |
100527-1 | http://loinc.org | Recreational therapy Outpatient Progress note |
100528-9 | http://loinc.org | Reproductive endocrinology and infertility Outpatient Progress note |
10052-9 | http://loinc.org | S wave duration in lead V1 |
100529-7 | http://loinc.org | Research Outpatient Progress note |
100530-5 | http://loinc.org | Rheumatology Outpatient Progress note |
100531-3 | http://loinc.org | Sleep medicine Outpatient Progress note |
100532-1 | http://loinc.org | Social worker Outpatient Progress note |
100533-9 | http://loinc.org | Solid Organ Transplant Outpatient Progress note |
100534-7 | http://loinc.org | Speech-language pathology Outpatient Progress note |
100535-4 | http://loinc.org | Spinal surgery Outpatient Progress note |
100536-2 | http://loinc.org | Sports medicine Outpatient Progress note |
10053-7 | http://loinc.org | S wave duration in lead V2 |
100537-0 | http://loinc.org | Surgery of the hand Outpatient Progress note |
100538-8 | http://loinc.org | Telehealth+Outpatient Progress note |
100539-6 | http://loinc.org | Thromboembolism Outpatient Progress note |
100540-4 | http://loinc.org | Transplant surgery Outpatient Progress note |
100541-2 | http://loinc.org | Trauma Outpatient Progress note |
100542-0 | http://loinc.org | Urology Outpatient Progress note |
100543-8 | http://loinc.org | Vascular neurology Outpatient Progress note |
100544-6 | http://loinc.org | Vascular surgery Outpatient Progress note |
10054-5 | http://loinc.org | S wave duration in lead V3 |
100545-3 | http://loinc.org | Wound care management Outpatient Progress note |
100546-1 | http://loinc.org | Wound, Ostomy, and Continence Care Outpatient Progress note |
100547-9 | http://loinc.org | Adolescent medicine Hospital Progress note |
100548-7 | http://loinc.org | Allergy and Immunology Hospital Progress note |
100549-5 | http://loinc.org | Allergy Hospital Progress note |
100550-3 | http://loinc.org | Attending Hospital Progress note |
100551-1 | http://loinc.org | Audiology Hospital Progress note |
10055-2 | http://loinc.org | S wave duration in lead V4 |
100552-9 | http://loinc.org | Bariatric surgery Hospital Progress note |
100553-7 | http://loinc.org | Blood banking and transfusion medicine Hospital Progress note |
100554-5 | http://loinc.org | Bone Marrow Transplant Hospital Progress note |
100555-2 | http://loinc.org | Breastfeeding Hospital Progress note |
100556-0 | http://loinc.org | Burn management Hospital Progress note |
100557-8 | http://loinc.org | Cardiac surgery Hospital Progress note |
100558-6 | http://loinc.org | Cardiopulmonary Hospital Progress note |
100559-4 | http://loinc.org | Child and adolescent psychiatry Hospital Progress note |
10056-0 | http://loinc.org | S wave duration in lead V5 |
100560-2 | http://loinc.org | Clinical cardiac electrophysiology Hospital Progress note |
100561-0 | http://loinc.org | Clinical genetics Hospital Progress note |
100562-8 | http://loinc.org | Clinical neurophysiology Hospital Progress note |
100563-6 | http://loinc.org | Clinical pathology Hospital Progress note |
100564-4 | http://loinc.org | Colon and rectal surgery Hospital Progress note |
100565-1 | http://loinc.org | Consultant Hospital Progress note |
100566-9 | http://loinc.org | Dentistry Hospital Progress note |
100567-7 | http://loinc.org | Dermatology Hospital Progress note |
100568-5 | http://loinc.org | Developmental-behavioral pediatrics Hospital Progress note |
100569-3 | http://loinc.org | Dialysis and Therapeutic apheresis Hospital Progress note |
100570-1 | http://loinc.org | Eating disorders Hospital Progress note |
100571-9 | http://loinc.org | Endocrinology Hospital Progress note |
100572-7 | http://loinc.org | Family medicine Hospital Progress note |
100573-5 | http://loinc.org | Gastroenterology Hospital Progress note |
100574-3 | http://loinc.org | General medicine Hospital Progress note |
100575-0 | http://loinc.org | Geriatric medicine Hospital Progress note |
100576-8 | http://loinc.org | Gynecologic oncology Hospital Progress note |
100577-6 | http://loinc.org | Gynecology Hospital Progress note |
10057-8 | http://loinc.org | S wave duration in lead V6 |
100578-4 | http://loinc.org | Healthcare navigator Hospital Progress note |
100579-2 | http://loinc.org | Heart failure Hospital Progress note |
1005-8 | http://loinc.org | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |
100580-0 | http://loinc.org | Heart failure+Transplant cardiology Hospital Progress note |
100581-8 | http://loinc.org | Hematology Hospital Progress note |
100582-6 | http://loinc.org | Hematology+Medical oncology Hospital Progress note |
100583-4 | http://loinc.org | Hepatology Hospital Progress note |
100584-2 | http://loinc.org | Immunology Hospital Progress note |
100585-9 | http://loinc.org | Infectious disease Hospital Progress note |
10058-6 | http://loinc.org | S' wave amplitude in lead AVF |
100586-7 | http://loinc.org | Internal medicine Hospital Progress note |
100587-5 | http://loinc.org | Interventional cardiology Hospital Progress note |
100588-3 | http://loinc.org | Interventional radiology Hospital Progress note |
100589-1 | http://loinc.org | Hospital Mechanical circulatory support Progress note |
100590-9 | http://loinc.org | Medical Aid in Dying Hospital Progress note |
100591-7 | http://loinc.org | Mental health Hospital Progress note |
100592-5 | http://loinc.org | Multi-specialty program Hospital Progress note |
100593-3 | http://loinc.org | Neonatal perinatal medicine Hospital Progress note |
10059-4 | http://loinc.org | S' wave amplitude in lead AVL |
100594-1 | http://loinc.org | Nephrology Hospital Progress note |
100595-8 | http://loinc.org | Neurological surgery Hospital Progress note |
100596-6 | http://loinc.org | Neurology Hospital Progress note |
100597-4 | http://loinc.org | Neurology with special qualifications in child neurology Hospital Progress note |
100598-2 | http://loinc.org | Nurse practitioner Hospital Progress note |
100599-0 | http://loinc.org | Nurse Hospital Progress note |
100600-6 | http://loinc.org | Nutrition and dietetics Hospital Progress note |
100601-4 | http://loinc.org | Obstetrics and Gynecology Hospital Progress note |
10060-2 | http://loinc.org | S' wave amplitude in lead AVR |
100602-2 | http://loinc.org | Obstetrics Hospital Progress note |
100603-0 | http://loinc.org | Occupational therapy Hospital Progress note |
100604-8 | http://loinc.org | Oncology Hospital Progress note |
100605-5 | http://loinc.org | Ophthalmology Hospital Progress note |
100606-3 | http://loinc.org | Oral and Maxillofacial Surgery Hospital Progress note |
100607-1 | http://loinc.org | Orthopaedic surgery Hospital Progress note |
100608-9 | http://loinc.org | Orthotics prosthetics Hospital Progress note |
100609-7 | http://loinc.org | Otolaryngology Hospital Progress note |
10061-0 | http://loinc.org | S' wave amplitude in lead I |
100610-5 | http://loinc.org | Pain medicine Hospital Progress note |
100611-3 | http://loinc.org | Palliative care Hospital Progress note |
100612-1 | http://loinc.org | Pastoral care Hospital Progress note |
100613-9 | http://loinc.org | Pediatric cardiology Hospital Progress note |
100614-7 | http://loinc.org | Pediatric dermatology Hospital Progress note |
100615-4 | http://loinc.org | Pediatric endocrinology Hospital Progress note |
100616-2 | http://loinc.org | Pediatric gastroenterology Hospital Progress note |
100617-0 | http://loinc.org | Pediatric hematology-oncology Hospital Progress note |
100618-8 | http://loinc.org | Pediatric infectious diseases Hospital Progress note |
100619-6 | http://loinc.org | Pediatric otolaryngology Hospital Progress note |
100620-4 | http://loinc.org | Pediatric pulmonology Hospital Progress note |
100621-2 | http://loinc.org | Pediatric rheumatology Hospital Progress note |
100622-0 | http://loinc.org | Pediatric surgery Hospital Progress note |
100623-8 | http://loinc.org | Pediatric transplant hepatology Hospital Progress note |
100624-6 | http://loinc.org | Pharmacogenomics Hospital Progress note |
100625-3 | http://loinc.org | Pharmacology Hospital Progress note |
100626-1 | http://loinc.org | Physical medicine and rehab Hospital Progress note |
100627-9 | http://loinc.org | Physical therapy Hospital Progress note |
10062-8 | http://loinc.org | S' wave amplitude in lead II |
100628-7 | http://loinc.org | Plastic surgery Hospital Progress note |
100629-5 | http://loinc.org | Podiatry Hospital Progress note |
100630-3 | http://loinc.org | Psychology Hospital Progress note |
100631-1 | http://loinc.org | Radiation oncology Hospital Progress note |
100632-9 | http://loinc.org | Radiology Hospital Progress note |
100633-7 | http://loinc.org | Rapid response team Hospital Progress note |
100634-5 | http://loinc.org | Recreational therapy Hospital Progress note |
100635-2 | http://loinc.org | Reproductive endocrinology and infertility Hospital Progress note |
10063-6 | http://loinc.org | S' wave amplitude in lead III |
100636-0 | http://loinc.org | Research Hospital Progress note |
100637-8 | http://loinc.org | Rheumatology Hospital Progress note |
100638-6 | http://loinc.org | Sleep medicine Hospital Progress note |
100639-4 | http://loinc.org | Social worker Hospital Progress note |
100640-2 | http://loinc.org | Solid Organ Transplant Hospital Progress note |
100641-0 | http://loinc.org | Speech-language pathology Hospital Progress note |
100642-8 | http://loinc.org | Spinal surgery Hospital Progress note |
100643-6 | http://loinc.org | Surgery of the hand Hospital Progress note |
10064-4 | http://loinc.org | S' wave amplitude in lead V1 |
100644-4 | http://loinc.org | Thromboembolism Hospital Progress note |
100645-1 | http://loinc.org | Trauma Hospital Progress note |
100646-9 | http://loinc.org | Urology Hospital Progress note |
100647-7 | http://loinc.org | Vascular neurology Hospital Progress note |
100648-5 | http://loinc.org | Vascular surgery Hospital Progress note |
100649-3 | http://loinc.org | Wound care management Hospital Progress note |
100650-1 | http://loinc.org | Wound, Ostomy, and Continence Care Hospital Progress note |
10065-1 | http://loinc.org | S' wave amplitude in lead V2 |
100651-9 | http://loinc.org | Hospital COVID-19 Intubation Progress note |
100652-7 | http://loinc.org | Pure tone bone conduction threshold audiometry panel |
100653-5 | http://loinc.org | Pure tone air conduction threshold audiometry panel |
100654-3 | http://loinc.org | Pyruvate kinase M2 [Presence] in Stool |
100655-0 | http://loinc.org | XR Sella turcica Lateral |
100656-8 | http://loinc.org | Maternal and fetal medicine Outpatient Progress note |
100657-6 | http://loinc.org | Maternal and fetal medicine Telephone encounter+Hospital Progress note |
100658-4 | http://loinc.org | Hospital COVID-19 Progress note |
100659-2 | http://loinc.org | Maternal and fetal medicine Hospital Progress note |
1006-6 | http://loinc.org | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |
100660-0 | http://loinc.org | Maternal and fetal medicine Telephone encounter+Outpatient Progress note |
100661-8 | http://loinc.org | Psychiatry Outpatient Progress note |
100662-6 | http://loinc.org | Cortisol free and total panel - Serum or Plasma |
100663-4 | http://loinc.org | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method |
100664-2 | http://loinc.org | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method |
100665-9 | http://loinc.org | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method |
100666-7 | http://loinc.org | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method |
100667-5 | http://loinc.org | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method |
100668-3 | http://loinc.org | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method |
10066-9 | http://loinc.org | S' wave amplitude in lead V3 |
100669-1 | http://loinc.org | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method |
100670-9 | http://loinc.org | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus |
100671-7 | http://loinc.org | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection |
100672-5 | http://loinc.org | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection |
100673-3 | http://loinc.org | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection |
100674-1 | http://loinc.org | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
100675-8 | http://loinc.org | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
100676-6 | http://loinc.org | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection |
10067-7 | http://loinc.org | S' wave amplitude in lead V4 |
100677-4 | http://loinc.org | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
100678-2 | http://loinc.org | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
100679-0 | http://loinc.org | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
100680-8 | http://loinc.org | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
100681-6 | http://loinc.org | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
100682-4 | http://loinc.org | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
100683-2 | http://loinc.org | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
100684-0 | http://loinc.org | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
10068-5 | http://loinc.org | S' wave amplitude in lead V5 |
100685-7 | http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
100686-5 | http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
100687-3 | http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |
100688-1 | http://loinc.org | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
100689-9 | http://loinc.org | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection |
100690-7 | http://loinc.org | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection |
100691-5 | http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
100692-3 | http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
10069-3 | http://loinc.org | S' wave amplitude in lead V6 |
100693-1 | http://loinc.org | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection |
100694-9 | http://loinc.org | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method |
100695-6 | http://loinc.org | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative |
100696-4 | http://loinc.org | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal |
100697-2 | http://loinc.org | Interventional radiology Outpatient Note |
100698-0 | http://loinc.org | Social Determinants of Health screening report Document |
100699-8 | http://loinc.org | Rifabutin+Ethambutol [Susceptibility] |
100700-4 | http://loinc.org | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection |
10070-1 | http://loinc.org | S' wave duration in lead AVF |
100701-2 | http://loinc.org | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection |
100702-0 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection |
100703-8 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection |
100704-6 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection |
100705-3 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection |
100706-1 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection |
100707-9 | http://loinc.org | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count |
100708-7 | http://loinc.org | Plasma cells/100 leukocytes in Synovial fluid |
100709-5 | http://loinc.org | Hepatocellular carcinoma risk [Score] by GAAD |
100710-3 | http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection |
100711-1 | http://loinc.org | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay |
100712-9 | http://loinc.org | Brexpiprazole [Mass/volume] in Serum or Plasma |
100713-7 | http://loinc.org | Cariprazine [Mass/volume] in Serum or Plasma |
100714-5 | http://loinc.org | Guanfacine [Mass/volume] in Serum or Plasma |
100715-2 | http://loinc.org | Prothipendyl [Mass/volume] in Serum or Plasma |
100716-0 | http://loinc.org | Prostate specific Ag [Mass/volume] in DBS |
100717-8 | http://loinc.org | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method |
100718-6 | http://loinc.org | Undersea and hyperbaric medicine Discharge summary |
10071-9 | http://loinc.org | S' wave duration in lead AVL |
100719-4 | http://loinc.org | Surgical oncology Discharge summary |
100720-2 | http://loinc.org | Reproductive endocrinology and infertility Discharge summary |
100721-0 | http://loinc.org | Community health care Discharge summary |
100722-8 | http://loinc.org | Integrative medicine Discharge summary |
100723-6 | http://loinc.org | Sports medicine Discharge summary |
100724-4 | http://loinc.org | Diabetology Discharge summary |
100725-1 | http://loinc.org | Optometry Discharge summary |
100726-9 | http://loinc.org | Podiatry Discharge summary |
10072-7 | http://loinc.org | S' wave duration in lead AVR |
100727-7 | http://loinc.org | Chiropractic medicine Discharge summary |
100728-5 | http://loinc.org | Cardiac surgery Discharge summary |
100729-3 | http://loinc.org | Breastfeeding Discharge summary |
100730-1 | http://loinc.org | Transplant surgery Discharge summary |
100731-9 | http://loinc.org | Urgent care center Discharge summary |
100732-7 | http://loinc.org | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum |
100733-5 | http://loinc.org | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) |
100734-3 | http://loinc.org | traMADol and Metabolites Panel - Urine by Confirmatory method |
10073-5 | http://loinc.org | S' wave duration in lead I |
100735-0 | http://loinc.org | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes |
100736-8 | http://loinc.org | Acylcarnitine Analysis Post Mortem in Specimen Document |
100737-6 | http://loinc.org | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma |
100738-4 | http://loinc.org | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma |
100739-2 | http://loinc.org | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma |
1007-4 | http://loinc.org | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells |
100740-0 | http://loinc.org | Amylase.macromolecular [Presence] in Serum or Plasma |
100741-8 | http://loinc.org | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma |
100742-6 | http://loinc.org | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma |
10074-3 | http://loinc.org | S' wave duration in lead II |
100743-4 | http://loinc.org | Lipase.macromolecular [Presence] in Serum or Plasma |
100744-2 | http://loinc.org | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis |
100745-9 | http://loinc.org | Chloride [Moles/volume] in Mixed venous blood |
100746-7 | http://loinc.org | Glucose [Moles/volume] in Mixed venous blood |
100747-5 | http://loinc.org | Legionella serogroup panel - Specimen |
100748-3 | http://loinc.org | Legionella spp [Presence] in Specimen by NAA with probe detection |
100749-1 | http://loinc.org | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection |
10075-0 | http://loinc.org | S' wave duration in lead III |
100750-9 | http://loinc.org | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection |
100751-7 | http://loinc.org | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma |
100752-5 | http://loinc.org | Exacerbating factors - Reported |
100753-3 | http://loinc.org | Alleviating factors - Reported |
100754-1 | http://loinc.org | Platelet disorders multigene analysis in Blood or Tissue by Sequencing |
100755-8 | http://loinc.org | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing |
100756-6 | http://loinc.org | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing |
100757-4 | http://loinc.org | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing |
100758-2 | http://loinc.org | Estimated lung age by based on clinical data |
100759-0 | http://loinc.org | Inspiratory reserve [Volume] Respiratory system by Spirometry |
100760-8 | http://loinc.org | XR Radius and Ulna - left Single view |
100761-6 | http://loinc.org | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
100762-4 | http://loinc.org | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method |
100763-2 | http://loinc.org | Mycobacterium sp comparative reaction interpretation Narrative |
100764-0 | http://loinc.org | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal |
100765-7 | http://loinc.org | Homocysteine and methylmalonate and methylcitrate panel - DBS |
100766-5 | http://loinc.org | Center for Epidemiologic Studies Depression Scale panel [CES-D] |
100767-3 | http://loinc.org | Bothered by things that are not usually bothersome |
10076-8 | http://loinc.org | S' wave duration in lead V1 |
100768-1 | http://loinc.org | Poor appetite |
100769-9 | http://loinc.org | Unhappy even with help from my family or friends |
100770-7 | http://loinc.org | Feeling just as good as others |
100771-5 | http://loinc.org | Trouble focusing |
100772-3 | http://loinc.org | Feeling depressed |
100773-1 | http://loinc.org | Feeling everything is too much of an effort |
100774-9 | http://loinc.org | Feeling hopeful about the future |
100775-6 | http://loinc.org | Feeling life had been a failure |
10077-6 | http://loinc.org | S' wave duration in lead V2 |
100776-4 | http://loinc.org | Feeling fearful |
100777-2 | http://loinc.org | Restless sleep |
100778-0 | http://loinc.org | Feeling happy |
100779-8 | http://loinc.org | Quieter than usual |
100780-6 | http://loinc.org | Feeling lonely |
100781-4 | http://loinc.org | People were unfriendly |
100782-2 | http://loinc.org | Enjoying life |
100783-0 | http://loinc.org | Crying spells |
10078-4 | http://loinc.org | S' wave duration in lead V3 |
100784-8 | http://loinc.org | Feeling sad |
100785-5 | http://loinc.org | Feeling people dislike me |
100786-3 | http://loinc.org | Lack of energy |
100787-1 | http://loinc.org | Total Score CES-D |
100788-9 | http://loinc.org | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum |
100789-7 | http://loinc.org | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum |
100790-5 | http://loinc.org | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum |
100791-3 | http://loinc.org | Hamster epithelium IgG Ab [Mass/volume] in Serum |
10079-2 | http://loinc.org | S' wave duration in lead V4 |
100792-1 | http://loinc.org | Forsythia IgE Ab [Units/volume] in Serum |
100793-9 | http://loinc.org | Testosterone [Mass/volume] in Body fluid |
100794-7 | http://loinc.org | Follitropin [Units/volume] in Body fluid |
100795-4 | http://loinc.org | S100 calcium binding protein B [Mass/volume] in Body fluid |
100796-2 | http://loinc.org | Thyroglobulin [Mass/volume] in Body fluid |
100797-0 | http://loinc.org | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge |
100798-8 | http://loinc.org | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge |
100799-6 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge |
100-8 | http://loinc.org | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
10080-0 | http://loinc.org | S' wave duration in lead V5 |
100800-2 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge |
100801-0 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge |
100802-8 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge |
100803-6 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge |
100804-4 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge |
100805-1 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge |
100806-9 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge |
100807-7 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge |
100808-5 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge |
100809-3 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge |
100810-1 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge |
100811-9 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge |
100812-7 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge |
100813-5 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge |
100814-3 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge |
100815-0 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge |
100816-8 | http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
100817-6 | http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
10081-8 | http://loinc.org | S' wave duration in lead V6 |
100818-4 | http://loinc.org | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge |
100819-2 | http://loinc.org | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
1008-2 | http://loinc.org | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma |
100820-0 | http://loinc.org | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge |
100821-8 | http://loinc.org | National POLST form: portable medical order panel |
100822-6 | http://loinc.org | Cardiopulmonary resuscitation orders |
100823-4 | http://loinc.org | Initial portable medical treatment orders |
100824-2 | http://loinc.org | Additional portable medical orders or instructions |
100825-9 | http://loinc.org | Medically assisted nutrition orders |
10082-6 | http://loinc.org | ST initial amplitude 6 ms in lead AVF |
100826-7 | http://loinc.org | Portable medical order AndOr advance directive review |
100827-5 | http://loinc.org | Portable medical order discussion participants |
100828-3 | http://loinc.org | Portable medical order administrative information |
100829-1 | http://loinc.org | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge |
100830-9 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
100831-7 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
100832-5 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
100833-3 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
10083-4 | http://loinc.org | ST initial amplitude 6 ms in lead AVL |
100834-1 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
100835-8 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
100836-6 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
100837-4 | http://loinc.org | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
100838-2 | http://loinc.org | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
100839-0 | http://loinc.org | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma |
100840-8 | http://loinc.org | IgE [Units/volume] in Body fluid |
100841-6 | http://loinc.org | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot |
10084-2 | http://loinc.org | ST initial amplitude 6 ms in lead AVR |
100842-4 | http://loinc.org | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST |
100843-2 | http://loinc.org | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ |
100844-0 | http://loinc.org | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 |
100845-7 | http://loinc.org | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) |
100846-5 | http://loinc.org | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
100847-3 | http://loinc.org | Gas and ammonia panel - Arterial blood |
100848-1 | http://loinc.org | Cell count and Differential panel - Amniotic fluid by Manual count |
100849-9 | http://loinc.org | Leukocytes [#/volume] in Amniotic fluid by Manual count |
100850-7 | http://loinc.org | Neutrophils [#/volume] in Amniotic fluid by Manual count |
100851-5 | http://loinc.org | Other cells [#/volume] in Amniotic fluid by Manual count |
100852-3 | http://loinc.org | NM Bones Views for metastasis W Sr-89 IV |
100853-1 | http://loinc.org | NM Pericardial space Pericardial effusion |
100854-9 | http://loinc.org | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay |
100855-6 | http://loinc.org | CD3 cells/100 cells in Blood mononuclear cells |
100856-4 | http://loinc.org | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells |
100857-2 | http://loinc.org | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells |
100858-0 | http://loinc.org | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
10085-9 | http://loinc.org | ST initial amplitude 6 ms in lead I |
100859-8 | http://loinc.org | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
100860-6 | http://loinc.org | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
100861-4 | http://loinc.org | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
100862-2 | http://loinc.org | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
100863-0 | http://loinc.org | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
100864-8 | http://loinc.org | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method |
100865-5 | http://loinc.org | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection |
100866-3 | http://loinc.org | Febrile antibody profile in Serum |
10086-7 | http://loinc.org | ST initial amplitude 6 ms in lead II |
100867-1 | http://loinc.org | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay |
100868-9 | http://loinc.org | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method |
100869-7 | http://loinc.org | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method |
100870-5 | http://loinc.org | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method |
100871-3 | http://loinc.org | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method |
100872-1 | http://loinc.org | Bacteria producing polysaccharide from sucrose [Presence] in Isolate |
100873-9 | http://loinc.org | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method |
100874-7 | http://loinc.org | Basidiobolus sp [Presence] in Specimen |
10087-5 | http://loinc.org | ST initial amplitude 6 ms in lead III |
100875-4 | http://loinc.org | Fetal Heart Document limited US |
100876-2 | http://loinc.org | Fetal Heart Document US |
100877-0 | http://loinc.org | US Heart Transesophageal during surgery |
100878-8 | http://loinc.org | Endoscopic ultrasound study Upper GI tract Document |
100879-6 | http://loinc.org | US Guidance for cryoablation of Breast - right |
100880-4 | http://loinc.org | US Guidance for cryoablation of Breast - left |
100881-2 | http://loinc.org | MR Guidance for cryoablation of Bone |
100882-0 | http://loinc.org | MR Peritoneum W contrast percutaneous intraperitoneal |
10088-3 | http://loinc.org | ST initial amplitude 6 ms in lead V1 |
100883-8 | http://loinc.org | MR Guidance for biopsy of Kidney - left |
100884-6 | http://loinc.org | MR Guidance for biopsy of Kidney - right |
100885-3 | http://loinc.org | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection |
100886-1 | http://loinc.org | Orf virus DNA [Presence] in Specimen by NAA with probe detection |
100887-9 | http://loinc.org | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection |
100888-7 | http://loinc.org | Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection |
100889-5 | http://loinc.org | Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection |
100890-3 | http://loinc.org | Poxvirus DNA panel |
10089-1 | http://loinc.org | ST initial amplitude 6 ms in lead V2 |
100891-1 | http://loinc.org | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
100892-9 | http://loinc.org | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
100893-7 | http://loinc.org | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma |
100894-5 | http://loinc.org | Recommended screening frequency Narrative |
100895-2 | http://loinc.org | Rickettsia conorii IgG and IgM [Interpretation] in Serum |
100896-0 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge |
100897-8 | http://loinc.org | Staphylococcus aureus [Presence] in Specimen by Organism specific culture |
100898-6 | http://loinc.org | Lipid panel - Serum or Plasma |
100899-4 | http://loinc.org | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |